Phantom test procedures for a new neuro-oncological amino acid PET tracer: [18F]fluciclovine

被引:0
作者
Tsuzura, Kaede [1 ]
Wagatsuma, Kei [2 ,3 ]
Kamitaka, Yuto [3 ]
Miwa, Kenta [4 ]
Miyaji, Noriaki [4 ]
Kamiya, Takashi [1 ]
Yokotsuka, Noriyo [5 ]
Ishii, Kenji [3 ]
机构
[1] Osaka Univ Hosp, Dept Med Technol, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Kitasato Univ, Sch Allied Hlth Sci, 1-15-1 Kitazato,Minami Ku, Sagamihara, Kanagawa 2520373, Japan
[3] Tokyo Metropolitan Inst Geriatr & Gerontol, Res Team Neuroimaging, 35-2 Sakae Cho,Itabashi Ku, Tokyo 1730015, Japan
[4] Fukushima Med Univ, Sch Hlth Sci, Dept Radiol Sci, 10-6 Sakaemachi, Fukushima, Fukushima 9608516, Japan
[5] Teikyo Univ, Fac Med Technol, Dept Radiol Technol, 2-11-1 Kaga,Itabashi Ku, Tokyo 1738605, Japan
关键词
Amino acid; Glioma; Neuro-oncology; Quantitative evaluation; Standardization; POSITRON-EMISSION-TOMOGRAPHY; BRAIN-TUMORS; C-11-METHIONINE; ARTIFACTS;
D O I
10.1007/s12149-024-01973-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Amino acid positron emission tomography (PET) examinations using anti-1-amino-3-[F-18]-fluorocyclobutane-1-carboxylic acid ([F-18]FACBC) were allowed for routine clinical use in July 2024. However, phantom test procedures for [F-18]FACBC reconstruction parameters have not yet been established. The present study aimed to establish new phantom test procedures for [F-18]FACBC brain PET imaging to determine optimal reconstruction parameters. Methods: Background (BG) activity as well as hot sphere and target-to-background ratios (TBRs) of [F-18]FACBC were estimated based on brain activity and tumor-to-normal tissue ratios (TNR) in a Japanese clinical trial of [F-18]FACBC. Phantom experiments proceeded under [F-18]FACBC or L-[methyl-C-11]-methionine ([C-11]MET) conditions. The number of iterations and the Gaussian filter parameters were determined from the reconstruction parameters %contrast(mean) and coefficients of variation (CVs) in ordered subset expectation maximization (OSEM) and time-of-flight (TOF) with or without point-spread-function (PSF) correction. Results: The amounts of activity in the hot spheres and BG were 1.1 and 5.5 kBq/mL, respectively, and the TBR was 5.0 at the start of acquisition. The %contrast(mean) of all hot spheres was higher with [F-18]FACBC than [C-11]MET, and %contrast(mean) converged between 4 and 6 iterations in hot spheres with diameters < 10 mm. We used four iterations for OSEM + TOF and five for OSEM + TOF + PSF correction for [F-18]FACBC and [C-11]MET images. The CV was higher for [F-18]FACBC than [C-11]MET. The optimal sizes of Gaussian filters for OSEM + TOF and OSEM + TOF + PSF correction of image reconstruction were 5 mm for [F-18]FACBC, and 4 and 3 mm, respectively, for [C-11]MET images. Conclusions: We estimated phantom activity and TBR based on brain activity in a Japanese clinical trial and established new phantom test procedures for [F-18]FACBC. We recommend that the optimal reconstruction parameters for [F-18]FACBC should be set to the same number of iterations as [C-11]MET and that the FWHM of Gaussian filter should have a few mm higher than [C-11]MET to reduce image noise from brain normal tissue.
引用
收藏
页码:21 / 30
页数:10
相关论文
共 40 条
  • [1] New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies
    Akamatsu, Go
    Shimada, Naoki
    Matsumoto, Keiichi
    Daisaki, Hiromitsu
    Suzuki, Kazufumi
    Watabe, Hiroshi
    Oda, Keiichi
    Senda, Michio
    Terauchi, Takashi
    Tateishi, Ukihide
    [J]. ANNALS OF NUCLEAR MEDICINE, 2022, 36 (02) : 144 - 161
  • [2] Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study
    Akamatsu, Go
    Ikari, Yasuhiko
    Nishida, Hiroyuki
    Nishio, Tomoyuki
    Ohnishi, Akihito
    Maebatake, Akira
    Sasaki, Masayuki
    Senda, Michio
    [J]. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2015, 43 (03) : 222 - 226
  • [3] Phase I clinical study of NMK36: a new PET tracer with the synthetic amino acid analogue anti-[18F]FACBC
    Asano, Yuji
    Inoue, Yusuke
    Ikeda, Yasuhiko
    Kikuchi, Kei
    Hara, Toshimasa
    Taguchi, Chikako
    Tokushige, Takanori
    Maruo, Hideki
    Takeda, Tohoru
    Nakamura, Tomomi
    Fujita, Tomoe
    Kumagai, Yuji
    Hayakawa, Kazushige
    [J]. ANNALS OF NUCLEAR MEDICINE, 2011, 25 (06) : 414 - 418
  • [4] PET radiotracers in glioma: a review of clinical indications and evidence
    Castello, Angelo
    Castellani, Massimo
    Florimonte, Luigia
    Ciccariello, Gabriele
    Mansi, Luigi
    Lopci, Egesta
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2022, 10 (05) : 535 - 551
  • [5] Clinical applications of PET in brain tumors
    Chen, Wei
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (09) : 1468 - 1481
  • [6] Impact of point-spread function reconstruction on dynamic and static 18F-DOPA PET/CT quantitative parameters in glioma
    Girard, Antoine
    Francois, Madani
    Chaboub, Nibras
    Le Reste, Pierre-Jean
    Devillers, Anne
    Saint-Jalmes, Herve
    Le Jeune, Florence
    Palard-Novello, Xavier
    [J]. QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (02) : 1397 - 1404
  • [7] Value of 11C-methionine PET in imaging brain tumours and metastases
    Glaudemans, Andor W. J. M.
    Enting, Roelien H.
    Heesters, Mart A. A. M.
    Dierckx, Rudi A. J. O.
    van Rheenen, Ronald W. J.
    Walenkamp, Annemiek M. E.
    Slart, Riemer H. J. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 615 - 635
  • [8] Multimodality Assessment of Brain Tumors and Tumor Recurrence
    Heiss, Wolf-Dieter
    Raab, Peter
    Lanfermann, Heinrich
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (10) : 1585 - 1600
  • [9] Japanese Society of Nuclear Medicine, 2017, STANDARD PET IMAGING
  • [10] Feasibility of state of the art PET/CT systems performance harmonisation
    Kaalep, Andres
    Sera, Terez
    Rijnsdorp, Sjoerd
    Yaqub, Maqsood
    Talsma, Anne
    Lodge, Martin A.
    Boellaard, Ronald
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (08) : 1344 - 1361